Project
A multicenter, randomized, double-blind placebo controlled study to assess the effect of rasagiline on sleep-wake disturbance in patients with Parkinson's disease (PD)
Automatically Closed · 2011 until 2013
Kägi Georg
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2011
End Date
2013
Financing
Industry
Brief description/objective
A multicenter, randomized, double-blind placebo controlled study to assess the effect of rasagiline on sleep-wake disturbance in patients with Parkinson's disease (PD)